TXN2
Basic information
Region (hg38): 22:36467046-36481640
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation defect type 29 (Supportive), mode of inheritance: AR
- combined oxidative phosphorylation deficiency 29 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 29 | AR | Biochemical | Medical management (with coenzyme Q10) has been described as beneficial | Biochemical; Neurologic | 26626369 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TXN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 11 | ||||
missense | 22 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 2 | ||||
non coding | 8 | |||||
Total | 0 | 0 | 23 | 15 | 5 |
Variants in TXN2
This is a list of pathogenic ClinVar variants found in the TXN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-36467627-CCT-C | Benign (May 19, 2021) | |||
22-36467804-T-G | Uncertain significance (Apr 27, 2023) | |||
22-36467809-C-T | not specified | Uncertain significance (Jul 19, 2022) | ||
22-36467811-A-G | not specified | Uncertain significance (May 04, 2023) | ||
22-36467825-G-A | Likely benign (May 08, 2023) | |||
22-36467836-A-G | Likely benign (Dec 31, 2019) | |||
22-36467860-C-A | not specified | Uncertain significance (Jun 10, 2024) | ||
22-36467876-G-A | Likely benign (Jul 13, 2022) | |||
22-36467918-C-T | not specified | Uncertain significance (Jul 20, 2023) | ||
22-36467932-C-T | Likely benign (Mar 13, 2022) | |||
22-36468016-G-T | Benign (May 19, 2021) | |||
22-36476703-T-G | Combined oxidative phosphorylation deficiency 29 | Benign (Dec 05, 2021) | ||
22-36476725-A-G | Likely benign (Dec 11, 2023) | |||
22-36476744-T-C | Combined oxidative phosphorylation deficiency 29 • not specified | Uncertain significance (Jan 31, 2023) | ||
22-36476775-C-T | Likely benign (Apr 25, 2018) | |||
22-36476776-T-C | not specified | Uncertain significance (Jan 31, 2023) | ||
22-36476786-C-G | Uncertain significance (Nov 13, 2021) | |||
22-36476796-G-A | Likely benign (Aug 24, 2022) | |||
22-36476807-C-A | not specified | Uncertain significance (Jul 20, 2021) | ||
22-36476813-T-C | Uncertain significance (Jan 15, 2024) | |||
22-36476817-C-T | Likely benign (Jul 12, 2022) | |||
22-36476826-C-T | Combined oxidative phosphorylation deficiency 29 • TXN2-related disorder | Benign/Likely benign (Jul 01, 2024) | ||
22-36476827-G-A | Uncertain significance (Mar 04, 2022) | |||
22-36476865-GC-AG | Likely benign (Nov 28, 2023) | |||
22-36476866-C-T | Likely benign (Nov 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TXN2 | protein_coding | protein_coding | ENST00000216185 | 3 | 14995 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000256 | 0.325 | 125729 | 0 | 18 | 125747 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.615 | 79 | 95.9 | 0.823 | 0.00000499 | 1078 |
Missense in Polyphen | 17 | 30.716 | 0.55347 | 371 | ||
Synonymous | -0.624 | 44 | 39.0 | 1.13 | 0.00000219 | 345 |
Loss of Function | 0.0508 | 7 | 7.15 | 0.979 | 4.65e-7 | 67 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000213 | 0.000213 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000116 | 0.000114 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Important for the control of mitochondrial reactive oxygen species homeostasis, apoptosis regulation and cell viability. Possesses a dithiol-reducing activity. {ECO:0000269|PubMed:12032145, ECO:0000269|PubMed:12080052, ECO:0000269|PubMed:26626369}.;
- Pathway
- NOD-like receptor signaling pathway - Homo sapiens (human);Fluid shear stress and atherosclerosis - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Oxidative Stress;Detoxification of Reactive Oxygen Species;Cellular responses to stress;Degradation of cysteine and homocysteine;Metabolism of amino acids and derivatives;Metabolism;Cellular responses to external stimuli;Sulfur amino acid metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.605
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 28.63
Haploinsufficiency Scores
- pHI
- 0.305
- hipred
- N
- hipred_score
- 0.219
- ghis
- 0.625
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Txn2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype;
Gene ontology
- Biological process
- sulfur amino acid catabolic process;response to hypoxia;glycerol ether metabolic process;response to oxidative stress;response to hormone;response to glucose;response to organic cyclic compound;cellular response to nutrient levels;response to drug;cell redox homeostasis;response to axon injury;oxidation-reduction process
- Cellular component
- nucleolus;mitochondrion;mitochondrial matrix;dendrite;neuronal cell body
- Molecular function
- protein binding;peptide-methionine (S)-S-oxide reductase activity;protein disulfide oxidoreductase activity;peptide-methionine (R)-S-oxide reductase activity;protein-containing complex binding